Medgene Receives Emergency Use Authorization for RHDV2 Vaccine

Rabbit Hemorrhagic Disease has quickly spread across the United States. Working with the USDA, Medgene Labs responds with a vaccine developed on its prescription platform technology.    Medgene Labs, a vaccine and immunological services provider based in Brookings, SD, has received emergency use authorization for their experimental Rabbit Hemorrhagic Disease Virus 2 (RHDV2) vaccine from the … Continue reading Medgene Receives Emergency Use Authorization for RHDV2 Vaccine